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Abstract: Background: To our knowledge no study has focused on the pattern of cereal-based
products (CBP) consumption among people with celiac disease (CD). Our study aimed at evaluating
the dietary intake of CBP among patients with CD and comparing it with a control population.
Methods: Eighty-two volunteers with CD and 77 non-CD volunteers enrolled throughout Italy were
asked to register their consumption of CBP on specific diaries for three days. Results: CD patients’
median three-day intake of biscuits and crackers was higher compared to controls (65.8 g vs. 22.7 g
and 44.7 g vs. 10.6 g, p < 0.05 respectively, Mann–Whitney test). A significant difference was
observed also comparing the two groups for median three-day bread consumption, with the CD
group consuming less bread than controls (109.5 g vs. 150.7 g, p < 0.05, Mann–Whitney test).
When assessing regional and gender-related CBP consumption patterns, significantly higher rice
consumption was found among CD women from Northern Italy compared to CD women from
Central and Southern Italy (p = 0.006 and p = 0.002 respectively, Fisher’s exact test). No other
significant differences were observed. Conclusions: Our results provide a snapshot of the overall
consumption of CBP among Italian subjects with CD. Altogether, these data show that, despite minor
differences, dietary consumption of CBP among CD patients is similar to the general population.
Keywords: celiac disease; cereal-based products; gluten-free diet; nutrition; dietary survey
1. Introduction
Celiac disease (CD) is an immune-mediated systemic disorder triggered by the ingestion of gluten
and related prolamines in genetically susceptible individuals [1].
The prevalence of CD varies from 4.5% among first-degree relatives of CD-affected patients to
0.5%–1.0% in the general population [2,3] and is increasing over time [4,5]. The frequency increase
is partially related to improved diagnostic rates, as a result of increased awareness by health care
professionals and the easy access to reliable serologic testing [6]; however, a true increase of prevalence
has also been identified and this could be attributable to still elusive and hypothetical environmental
triggers [7].
A strict gluten-free diet (GFD) is the only available treatment for CD: it relieves symptoms,
achieves mucosal healing, and prevents disease complications [8,9]. However, many patients find it
difficult to comply with the diet [10]. GFD consists of a combination of naturally occurring gluten-free
foods (e.g., gluten-free cereals, fruit, vegetables, unprocessed meat, fish) and specially manufactured
gluten-free substitutes of wheat-based foods such as pasta, bread, cereals, crackers, and snack foods,
in which wheat flour is replaced by gluten-free flour [11].
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Although conceptually simple, the changes imposed on the daily diet are substantial and
have a profound effect on the dietary habits of CD patients and their families. There are many
barriers to the GFD, including the availability, cost, and safety of gluten-free food and gluten
cross-contamination [12,13].
Regular follow-up visits are needed to assess compliance, as well as to ensure nutritional adequacy
and prevent overnutrition while adhering to a lifelong GFD [14]. Patients pursuing their everyday
gluten avoidance might overlook the importance of eating a balanced diet. The GFD definitely restricts
food choices and has been identified as a possible cause of inadequate nutrient intake [15–17]. Most
commercial gluten-free foods are alternatives to traditional wheat-based products and it has often been
stated that gluten-free processed foods are less healthy than their gluten-containing counterparts, due
to relatively higher content of fat, sugar, and salt [18,19], but current data on this issue are scarce [20].
To our knowledge no study has focused on the pattern of cereal-based products (CBP)
consumption among people with CD. The present study aimed at assessing the dietary intake of
CBP among CD patients compared to a group of healthy controls.
2. Materials and Methods
Eighty-two volunteers with biopsy-proven CD and 77 non-CD healthy volunteers were enrolled
in this study through our internal patient database (Rome and Ancona) and via Italian Celiac Society
social media (magazine, newsletters, websites, email, Facebook and Twitter) from November 2011
to March 2013. Controls were not significantly different in terms of age or gender and were chosen
among friends or colleagues of CD patients. General exclusion criteria for both CD and control group
were a diagnosis of diabetes mellitus (both type-1 and type-2), anorexia, bulimia, food allergy or being
on a restricted diet for other medical/ethical/religious reasons (including non-celiac gluten sensitivity
among controls). A specific exclusion criterion for the CD group was a CD diagnosis within one year
from the recruitment time. Being a family member of CD patients was an additional exclusion criterion
for the control group.
Demographics of study participants are summarized in Table 1.
All subjects received oral and written information about the nature and purpose of the survey
and all of them formally consented to the study. This study was approved by the Ethical Committee of
the Politecnica delle Marche University of Ancona, Italy (N533/Oct 2011).
Dietary intakes of CD patients and controls were collected using a three-day food diary.
All participants recorded their consumption of CBP for 3 consecutive days using a specific dietary diary.
A list of the food item to be registered was provided to the study subjects. Alongside with
this list, an example sheet guiding participant to correctly fill the boxes was also given. Main meals
and additional snacks between main meals were represented as specific boxes to fill on the data
sheet. During the days of the survey, participants were advised to maintain their usual eating habits.
Volunteers registered ingested CBP in detail, specifying the type, brand, and weight by means of a
digital scale. For each “out of home” meal, instead of weighing they had been allowed to use a photo
atlas to determine the weight of food consumed (photo atlas of food portions, Istituto Scotti Bassani
2008). “Out of home” meals accounted for 5.1% of all recorded meals.
The consumption over three days of sweet pastries (processed plum cakes, muffins and croissants),
bread, pasta, pizza, homemade cakes, biscuits, crackers, breakfast cereals, breadcrumbs, and other
cereals of the CD group was compared with that of the control group.
Data were expressed as median daily and three-day consumption of each CBP category.
The Mann–Whitney test was used for comparisons. For regional subgroup analysis, data were
expressed as the median three-day consumption or percentage of consumption (consumers vs.
non-consumers) during the three days of the survey. The Mann–Whitney test or Fisher’s exact
test were used to compare subgroup data as appropriate. Statistical analysis was performed by Prism
software version 5.00 (GraphPad, San Diego, CA, USA).
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Table 1. Demographics of celiac and control participants.
Demographic Data Celiac Subjects Control Subjects
M/F ratio 14/68 20/57
Median age (range) 37 years (18–67) 37 years (18–68)
Median weight (range) 64.2 kg (47.2–88.6) 69.3 kg (52.8–90.1)
Median height (range) 168.9 cm (148.3–189.5) 166.1 cm (146.8–192.0)
3. Results
The median three-day consumption of CBP of CD patients and controls is represented in Figure 1.
Overall comparisons between the two groups are also summarized in Table 2. As far as the median
three-day consumption of different CBP, CD patients’ intake of bread was lower compared to controls
(109.5 g vs. 150.7 g, p < 0.05, Mann–Whitney test). Conversely, a significant higher median three-day
consumption of biscuits (65.8 g vs. 22.7 g, p < 0.05, Mann–Whitney test) and crackers (44.7 g vs. 10.6 g,
p < 0.05, Mann–Whitney test) was found among CD subjects compared to controls. As regards the
consumption of all the other CBP analyzed, no significant differences were observed between the CD
and the control group.
Among males, a higher daily intake of biscuits (41.2 g vs. 0 g, p < 0.05, Mann–Whitney test) and
a higher daily intake of crackers (13.8 g vs. 0 g, p < 0.05, Mann–Whitney test) were found among
CD subjects.
On the other hand, female subgroup analysis showed a reduced daily consumption of bread
among CD women compared to controls (33.2 g vs. 50.6 g, p < 0.05, Mann–Whitney test).
Tables 3 and 4 show consumption patterns (expressed in grams) of the two gender subgroups.
When assessing regional CBP consumption pattern, a significantly higher frequency in rice
consumption was found among CD women from Northern Italy (63%) compared to those from
Central (16%) and Southern Italy (8%) (p = 0.006 and p = 0.002 respectively, Fisher’s exact test).
No other significant differences were noticed with regard to regional and gender CBP consumption.
(supplementary figures)
When comparing daily CBP consumption pattern in CD and control groups according to food
processing (raw cereals vs. processed cereal-based products), we also found a similar distribution
between CD and control consumption patterns (Figure 2). We found that rice and corn were the
most consumed naturally GF cereals in the CD group, followed by millet and the pseudo-cereal
quinoa. Conversely, as regards naturally gluten-containing cereals, controls consumed mostly wheat
couscous, followed by kamut® and spelt. Raw cereal consumption in both group is represented
in Figures 3 and 4.
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Table 2. Consumption of cereal-based products in celiac disease (CD) subjects compared to controls.
Data are expressed as median three-day consumption and inter-quartile range. Mann–Whitney test
was used to compare group data.
Cereal-Based Products Celiac Population Control Population Statistics
Sweet Pastries 42.1 g (0–146) 40.2 g (0–100) p = ns
Bread 109.5 g (50–226) 150.7 g (80–234) p < 0.05
Pasta 160.0 g (92–254) 173.3 g (105–232) p = ns
Rice 0 g (0–99) 0 g (0-60) p = ns
Pizza 0 g (0–200) 0 g (0–248) p = ns
Homemade Cakes 0 g (0–0) 0 g (0–0) p = ns
Biscuits 65.8 g (12–104) 22.7 g (0–92) p < 0.05
Crackers 44.7 g (0–85) 10.6 g (0–65) p < 0.05
Polenta 0 g (0–0) 0 g (0–0) p = ns
Breakfast Cereals 0 g (0–57) 0 g (0–50) p = ns
Breadcrumb 0 g (0–0) 0 g (0–0) p = ns
Other Cereals 0 g (0–26) 0 g (0–43) p = ns
Table 3. Median and inter-quartile range daily consumption of cereal-based products in CD patients
and controls (males). Comparison was made by Mann–Whitney test.
Cereal-Based Products CD Subjects (Males) Controls (Males) Statistics
Sweet Pastries 3.5 g (0–68.4) 20.8 g (0–63) p = ns
Bread 69.1 g (47.2–125.6) 67.6 g (34.2–118.9) p = ns
Pasta 58.4 g (48.2–150.9) 108.3 g (90.1–156.9) p = ns
Rice 27.6 g (0–43.3) 0 g (0–0) p = ns
Pizza 0 g (0–41.8) 0 g (0–23.6) p = ns
Homemade Cakes 0 g (0–0) 0 g (0–0) p = ns
Biscuits 41.2 g (18.7–65.1) 0 g (0–27.1) p < 0.05
Crackers 13.8 g (0–29.2) 0 g (0–0) p < 0.05
Polenta 0 g (0–0) 0 g (0–0) p = ns
Breakfast Cereals 0 g (0–16.3) 0 g (0–58.5) p = ns
Breadcrumb 0 g (0–0) 0 g (0–0) p = ns
Other Cereals 0 g (0–0) 0 g (0–11.3) p = ns
Table 4. Median and inter-quartile range daily consumption of cereal-based products among CD
patients and controls (females). Comparison was made by Mann–Whitney test.
Cereal-Based Products CD Subjects(Females) Controls (Females) Statistics
Sweet Pastries 16.6 g (0–44.7) 13.2 g (0–26.8) p = ns
Bread 33.2 g (14.3–68.6) 50.6 g (27.2–80.4) p < 0.05
Pasta 53.3 g (31.0–84.6) 51.6 g (33.1–71.9) p = ns
Rice 0 g (0–31.1) 0 g (0–23.6) p = ns
Pizza 0 g (0–86.6) 0 g (0–83.2) p = ns
Homemade Cakes 0 g (0–0) 0 g (0–0) p = ns
Biscuits 19.6 g (0–33.0) 6.9 g (0–32.1) p = ns
Crackers 14.8 g (0–29.6) 6.6 g (0–22.1) p = ns
Polenta 0 g (0–0) 0 g (0–0) p = ns
Breakfast Cereals 0 g (0–34.1) 0 g (0–16.4) p = ns
Breadcrumb 0 g (0–2.5) 0 g (0–0) p = ns
Other Cereals 0 g (0–21.4) 0 g (0–34.6) p = ns
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GFD entails avoidance of the gluten-containing grains wheat, rye, and barley, whereas rice,
oats, buckwheat, corn, millet, and quinoa are included [22]. Although the availability of gluten-free
foods is still limited to some extent, recent years have witnessed a tremendous increase for the GF
market. As it was recently pointed out by a market research report, the GF products market is
experiencing a double-digit growth on a yearly basis [23]. This means that the GF product market
represents one of the most prosperous markets in the field of food and beverages in the next future.
Eating and baking gluten-free has become easier in recent years, with increases in the number and
quality of gluten-free products that are available on the Internet and in many stores today, albeit at
a greater expense compared to gluten-containing foods [11]. CD patients, at least in some Western
countries, receive financial assistance to compensate for this higher cost, and this support has also
been shown to enhance compliance rates [24]. Consumers can purchase packaged gluten-free breads,
buns, rolls, pizza crusts, donuts, pastas, pretzels, cereals, and desserts. Baking mixes and flours are
also available. The availability of gluten-free products increases patients’ food choices, improves diet
variety, while allowing patients to feel “normal” when eating with others [14], and improving also
dietary compliance [24].
Our study clearly showed that patients with CD tend to reproduce the pattern of CBP consumption
of healthy controls, as shown by the marked overlapping of the quantities of different products
consumed by the two groups. This is an interesting and somewhat unexpected finding given that
all CD patients at diagnosis are usually encouraged to increase their intake of naturally gluten-free
cereals (or pseudo-cereals) such as rice, corn, and buckwheat. In our opinion, difficulties in changing
structured eating behavior, poor diffusion of naturally GF cereals, and fear of gluten contamination are
the most likely explanation of this finding.
By comparing CD patients and controls, significant differences were observed only as regards
the consumption of bread, biscuits, and crackers. Biscuit and cracker consumption was higher
among CD patients than among controls, while bread intake was lower in the CD group compared
to controls. These data might underline that CD consumers rely more on biscuits and crackers
as sources of carbohydrates than the healthy population. This should drive both dieticians’ and
physicians’ thoughtful considerations of the nutritional adequacy of the GF diet, since biscuits show a
tendency to a higher glycemic index. As the lack of gluten itself may imply an overall increase of the
glycemic index [25], these data need a careful consideration due to their possible metabolic long-term
consequences. Moreover, GFD seems to increase the risk of excess weight and obesity because of the
nutritional imbalance and hypercaloric content of commercial gluten-free foods [26]. Additionally, the
content of highly absorbable sugars of the majority of these products can contribute to the occurrence
of hyperinsulinemia and insulin-resistance with overweight, thus leading to an increased risk of
metabolic syndrome [27]. Healthy food choices include a significant amount of dietary fiber, low
amounts of simple carbohydrates, and thus a lower glycemic index [28]. Consequently, CD individuals
may improve the overall nutritional quality of their diet by increasing the intake of fiber [20].
The CD group consumed less bread than controls. This trend could have two conceivable
interpretations: firstly, this different consumer choice could be possibly related to a current gap of
palatability with gluten-containing bread; secondly, a limited availability of freshly baked GF bread
could also limit the bread consumption and explain this result.
In our CD group, bread was prepared with several flour mixes available on the market. The main
components of these gluten-free flours were rice or maize, usually followed by rice starch and
potato starch.
The analysis of subgroup intakes showed a significantly higher consumption of rice among CD
women from Northern Italy when compared to CD women from Central and Southern Italy: we might
interpret this finding as a regional difference, mirroring other data on regional rice consumption [29],
albeit our control group did not show this pattern.
We are aware of certain drawbacks of our study. Firstly, the population sample enrolled included
a clear predominance of women (125 F:34 M), which goes beyond the expected higher CD prevalence in
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females than males (1.5–2:1). Women traditionally tend to show a greater interest and participate more
in nutritional surveys [30,31]. Other potential limitations of this survey were the variable accuracy
of self-reported data and possible dietary changes induced by the recording itself during the three
days of the study [32,33]. We also acknowledge that individuals’ nutrient intake may fluctuate on a
day-to-day basis due to a variety of factors, such as day of the week and season of the year [34], but we
still trust that the three-day recording method is a useful tool for population studies. Another potential
limitation of the survey might be the use of a “convenience sample” that included CD-patients being
members of celiac support groups and/or subscribers to a national magazine on CD, who may not be
representative of the general Italian celiac community.
5. Conclusions
Physicians and dieticians alike should carefully review the dietary pattern of celiac patients
at follow-up.
This is the first study reporting on the dietary intake of CBP among CD patients. Our results
snapshot overall consumption of CBP among Italian subjects with CD. We found a higher consumption
of crackers and biscuits among CD subjects; this was counterbalanced by a lower bread consumption
in the CD group. These results should encourage producers’ efforts in reducing glycemic index of
GF products and in increasing the palatability of GF bread. However, altogether these data show
that CD patients’ diet generally reproduce, despite minor differences, the eating behavior of the
general population.
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